BioCardia, Inc.
BCDA
$0.83
-$0.05-6.05%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -100.00% | -99.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -100.00% | -99.36% |
| Cost of Revenue | -0.19% | 13.11% | 27.16% | 3.45% | -28.97% |
| Gross Profit | 0.13% | -14.62% | -29.38% | -12.99% | 23.58% |
| SG&A Expenses | -16.62% | -9.69% | -9.98% | -8.95% | -11.99% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -7.53% | 2.72% | 9.59% | -1.99% | -22.27% |
| Operating Income | 7.50% | -3.46% | -10.59% | -2.88% | 18.80% |
| Income Before Tax | 7.34% | -3.55% | -10.59% | -2.75% | 18.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 7.34% | -3.55% | -10.59% | -2.75% | 18.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 7.34% | -3.55% | -10.59% | -2.75% | 18.83% |
| EBIT | 7.50% | -3.46% | -10.59% | -2.88% | 18.80% |
| EBITDA | 7.02% | -4.03% | -11.15% | -3.25% | 18.75% |
| EPS Basic | 59.80% | 57.78% | 59.12% | 60.99% | 63.39% |
| Normalized Basic EPS | 59.80% | 57.79% | 59.13% | 60.99% | 63.39% |
| EPS Diluted | 59.80% | 57.78% | 59.12% | 60.99% | 63.39% |
| Normalized Diluted EPS | 59.80% | 57.79% | 59.13% | 60.99% | 63.39% |
| Average Basic Shares Outstanding | 135.69% | 142.99% | 160.86% | 163.42% | 133.01% |
| Average Diluted Shares Outstanding | 135.69% | 142.99% | 160.86% | 163.42% | 133.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |